Moderna Inc., today announced the completion of enrollment for its COVID-19 vaccine phase 3 trial.
The drug maker said that it has confirmed 30,000 participants for an efficacy study of mRNA-1273. Moderna and the National Institute of Allergy and Infectious Diseasesdeveloped the candidate, which generated a strong
Related News
Moderna announces 30,000 participants enrolled in Phase 3 of COVID-19 vaccine trial
Moderna announced on Thursday that it had enrolled 30,000 participants in its Phase 3 COVID-19 vaccine trial, with more than 11,000 of those participants are from...
WPTV 2020-10-22COVID-19 Vaccine Appears Well-Tolerated and Effective in Developing Antibodies in Small Study of Older Adults
by Dr. Francis Collins It’s been truly breathtaking to watch the progress being made on a daily basis to develop safe and effective vaccines for SARS-CoV-2, the novel...
San Saba News 2020-10-22COVID-19 trials risk excluding those most vulnerable to virus
WASHINGTON — The elderly and communities of color have suffered disproportionately from the COVID-19 pandemic — and those groups are also at risk of being short-changed by...
Tyler Morning Telegraph
2020-10-22
Moderna's stock gains 3.5% after it completes enrollment in COVID-19 vaccine trial
Shares of Moderna Inc. MRNA, +3.19% gained 3.5% in trading on Thursday after it said it has completed enrollment of 30,000 participants in the Phase 3 clinical trial for...
Market Watch 2020-10-22Roundup: Moderna completes enrolling 30,000 participants for final stage COVID-19 vaccine trial
WASHINGTON, Oct. 22 (Xinhua) -- American pharmaceutical company Moderna, the first to start clinical trials of a COVID-19 vaccine in the United States, finished enrolling...
China.dot.org 2020-10-22Moderna Completes Enrollment in Large COVID-19 Vaccine Study
Moderna Inc. said on Thursday it had completed the enrollment of 30,000 participants in a late-stage study testing its experimental coronavirus vaccine, with over a third...
Hamodia 2020-10-22Moderna has competed enrollment of 30,000 diverse volunteers for its coronavirus vaccine trial, putting it ...
Moderna Inc announced on Thursday that it has completed enrollment of 30,000 volunteers for the final stage of its coronavirus vaccine trial. Additionally, the...
The Daily Mail 2020-10-22